- Rubis reported a revenue of €1.70 billion for the first quarter of 2025.
- The company witnessed a 4% increase in business volumes.
- Group EBITDA for 2025 is anticipated to be between €710 million and €760 million, with the assumption that hyperinflation impacts remain consistent with 2024.
- The company expressed confidence in its 2025 guidance.
- Rubis maintains confidence in its diverse business portfolio’s strength and growth potential.
- Current market recommendations include 6 buy ratings, 1 hold rating, and no sell recommendations for Rubis.
“`
A look at Rubis SCA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
When looking at the long-term outlook for Rubis SCA, the company seems to be in a solid position. With a high Smart Score of 5 in Dividend and Momentum, it indicates that Rubis SCA is performing well in terms of paying dividends to its investors and has positive momentum in its stock price. Additionally, scoring a 4 in both Value and Growth suggests that the company is undervalued and has good potential for growth in the future. However, with a slightly lower score of 3 in Resilience, it may indicate some vulnerability to market fluctuations.
Rubis SCA is involved in distributing liquefied petroleum gas and storing bulk liquids, including hydrocarbons, chemicals, fertilizers, and edible oils. With its primary focus on distributing LPG in Europe, the company plays a crucial role in the energy sector. The high scores in Dividend and Momentum reflect positively on Rubis SCA‘s ability to reward its investors and maintain a strong stock performance, while the scores in Value and Growth hint at promising opportunities for the company’s future development.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
